Hims & Hers Health (HIMS) Current Deferred Tax Assets (2020)

Hims & Hers Health's (HIMS) quarterly Current Deferred Tax Assets came in at $3.9 million in Q4 2020.

Hims & Hers Health (HIMS) Current Deferred Tax Assets (2020) Analysis & Trends

Hims & Hers Health has disclosed Current Deferred Tax Assets across 1 years of filings, most recently posting $3.9 million for Q4 2020.

Current Deferred Tax Assets for Q4 2020 came in at $3.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $3.9 million (changed N/A YoY), and the FY2020 annual result was $3.9 million, changed N/A from the prior year.
Current Deferred Tax Assets came in at $3.9 million for Q4 2020 at Hims & Hers Health.
In the past five years, Current Deferred Tax Assets ranged from a high of $3.9 million in Q4 2020 to a low of $3.9 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn

Download Data

Date	Value
Dec 31, 2020	3.93 Mn
Dec 31, 2020	3.93 Mn